We are live on
!
Find out more
DBIA
Dumont & Blake Investment Advisors Portfolio holdings
AUM
$445M
1-Year Est. Return
31.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+31.98%
3 Year Est. Return
+78.27%
5 Year Est. Return
+88.91%
10 Year Est. Return
+293.66%
AUM
$222M
AUM Growth
+$8.46M
(+4%)
Cap. Flow
-$1.44M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
26.08%
Holding
205
New
12
Increased
88
Reduced
53
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pultegroup
PHM
|
+$849K |
| 2 |
HBI
Hanesbrands
HBI
|
+$813K |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$455K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$439K |
| 5 |
Amazon
AMZN
|
+$221K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$927K |
| 2 |
HAR
Harman International Industries
HAR
|
+$620K |
| 3 |
PRA Group
PRAA
|
+$411K |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$403K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$319K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.96% |
| 2 | Healthcare | 8.82% |
| 3 | Financials | 8.8% |
| 4 | Consumer Discretionary | 6.18% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CALL
Viatris
VTRS
$19.3B
| $12K | 0.01% |
+300
| New | +$12.1K |
|
|
177
CALL
Bristol-Myers Squibb
BMY
$131B
| – | – |
-5,600
| Closed | -$327K |
|
178
CALL
CVS Health
CVS
$123B
| – | – |
-200
| Closed | -$16K |
|
179
CALL
GE Aerospace
GE
$383B
| – | – |
-104
| Closed | -$16K |
|
|
180
iShares US Medical Devices ETF
IHI
$3.37B
| – | – |
-41,760
| Closed | -$927K |
|
|
OPLN
181
CALL
Openlane
OPLN
$4.66B
| – | – |
-264
| Closed | -$4K |
|
182
CALL
MetLife
MET
$62.5B
| – | – |
-4,712
| Closed | -$226K |
|
183
CALL
Packaging Corp of America
PKG
$22.8B
| – | – |
-2,200
| Closed | -$187K |
|
|
184
Packaging Corp of America
PKG
$22.8B
| – | – |
-2,100
| Closed | -$178K |
|
|
185
PRA Group
PRAA
$781M
| – | – |
-10,506
| Closed | -$411K |
|
186
Transocean
RIG
$5.72B
| – | – |
-10,561
| Closed | -$156K |
|
|
HAR
187
DELISTED
Harman International Industries
HAR
| – | – |
-5,580
| Closed | -$620K |
|
|
GORX
188
DELISTED
GEOPHARMA INC
GORX
| $0 | ﹤0.01% |
40,000
| – | – |
|
Similar funds
BI
RWM
AFA
SGCM
WCP
FWSM
TC
CMP
Dumont & Blake Investment Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Dumont & Blake Investment Advisors held 205 positions worth $222M, up 4% from $213M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dumont & Blake Investment Advisors's Q1 2017 filing shows 12 new, 88 increased, 53 reduced and 14 closed positions. Its largest new stake was Pultegroup: 39,425 shares worth $928K. The largest sale was iShares US Medical Devices ETF, an estimated $927K.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
- Dumont & Blake Investment Advisors's largest Q1 2017 buy was Pultegroup: 39,425 shares worth $928K.
- Dumont & Blake Investment Advisors added most to Bristol-Myers Squibb in Q1 2017, an estimated $439K increase.
- Dumont & Blake Investment Advisors's biggest Q1 2017 reduction was L3 Technologies, Inc., cutting an estimated $403K.
- Dumont & Blake Investment Advisors fully exited iShares US Medical Devices ETF in Q1 2017, selling an estimated $927K.
- Dumont & Blake Investment Advisors's ten largest holdings make up 26% of its $222M portfolio in Q1 2017.
- Dumont & Blake Investment Advisors opened 12 new positions and closed 14 in Q1 2017.
- Dumont & Blake Investment Advisors's portfolio value rose 4% quarter-over-quarter to $222M.
Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2017, filed 4 May 2017.